Now that Pat McQuaid has been voted out of the UCI presidency and the troubled institution is being led by Brian Cookson, there is some reasonable hope that a Truth and Reconciliation Commission will be formed and testimony will take place. Given how cycling has been governed since the UCI was formed, this is a turn of events so surprising and unlikely it is befitting an Aaron Sorkin screenplay.
Let’s imagine it for a second: Someone will be willing to pay attention as Jesus Manzano speaks.
Consider that Floyd Landis and Tyler Hamilton will have an opportunity to sit down in the same room as members of the UCI, tell everything they saw and took part in while members of U.S. Postal and Phonak, and when finished Pat McQuaid won’t be there to call them “scumbags.”
Now that we have the faith that the UCI has a president who will actually do what he says, and that a Truth and Reconciliation Commission will convene, we have a question to consider: How far back should the TRC look? Technically, the choice of how far to look back belongs to Cookson or whoever he charges with running the TRC, but that Cookson is president now owes much to public outcry. We do have a voice and the success of a TRC will rest on public satisfaction.
So who should testify? The TRC should do more than just listen to riders and team personnel. We should hear from as many doctors, pharmacists and lab techs as possible. Let’s include the odd motorcycle driver or two. This testimony will be key in corroborating what the riders say. Anyone watching social media has noticed that there’s some suspicion about whether George Hincapie, Christian Vande Velde, David Zabriskie, Tom Danielson and Levi Leipheimer confessed all of their doping to USADA or not. Testimony from medical professionals and coaches will have the ability to confirm their previous testimony or demonstrate that they withheld some activity. It will also show just how fearful riders were of Travis Tygart, or not.
However, if the TRC only looks back as far as 1999, it won’t be far enough. We will have little reason to be satisfied. The TRC needs the freedom, resources and time necessary to take testimony from anyone with a heartbeat. That means we should listen to Belgian soigneurs from the 1950s. We should listen to guys like Lucien Aimar, who was a domestique for Jacques Anquetil. And yes, we should listen to Eddy Merckx.
Why go so far back? Because it will educate the sport’s governing body, riders, team staff, the public and sponsors—in short every stakeholder the sport has—on how entrenched doping and attitudes toward doping have been. Because it was ingrained at an institutional level, it will show that cycling takes doping not just more seriously than any other sport, but as seriously as one may take it. That is what will be necessary to win back sponsor and audience confidence.
The reality is that we won’t hear from everyone we would like to. We must also accept that the UCI is unlikely to allow the TRC to run for five years. They need to focus their effort, concentrate on the biggest part of the problem. To that end, I suggest that we do what we can to encourage testimony from as far back as 1990.
Based on everything I’ve learned about the rise of oxygen-vector doping, I think we can put a date on when doping fundamentally change in pro cycling. That date? May 18,1990. With it comes a specific location: Bari, Italy. That was the day and the location of the prologue for the 1990 Giro d’Italia, which was won by Gianni Bugno. Bugno went on to wear the pink jersey for the 19 days, all the way to the finish in Milan. It was the first time a rider had led the Giro from start to finish since Eddy Merckx did it in 1973. Because we know Bugno worked with Francesco Conconi and testing revealed a high hematocrit—for which he was sanctioned—I think it’s fair to mark this as the date when racing grand tours changed. Fair enough, that is, until we get testimony through a TRC.
Simply put, the 1990 Giro was the first grand tour won with the aid of EPO.
While EPO use changed the whole of racing, it had the greatest effect on the grand tours, where being able to stay out of the red zone thanks to extra red blood cells paid dividends as the race wore on. It was during the 1990 season that Bugno and Claudio Chiappucci stormed to prominence. A year later Miguel Indurain won his first Tour de France, and like Chiappucci and Bugno, Big Mig counted Conconi among his advisors.
The 1990 season was a turning point in that not only did it see the first grand tour won with the aid of EPO (the Giro), it also saw the last clean win in the Tour de France prior to two generations of wins tainted by oxygen-vector doping. Has there been a clean winner of the Tour since Greg LeMond’s 1990 win? Very probably, but certainly not between 1991 and 2006. The possibility of a clean winner seems to have grown more convincing with each year since 2007.
A TRC has the ability to settle this question.
Now, regarding LeMond, it’s easy enough to find comments on Facebook or Twitter from people willing to accuse him of having doped. Even without a TRC, the evidence suggests that in 1989 each of the grand tours was won without oxygen-vector doping. The Vuelta was won by Pedro Delgado, the Giro by Laurent Fignon and the Tour by LeMond. Each of those guys had won a grand tour prior to the availability of EPO. While we know that both Delgado and Fignon doped, we have reason to believe they weren’t using EPO in ’89. What’s interesting about ’89 is that this is the year Chiappucci, Bugno and Indurain began to threaten the GC. In ’89 Chiappucci finished 46th and 81st in the Giro and Tour, respectively. A year later? A remarkable 12th and 2nd. In ’88, Bugno withdrew from the Giro and finished the Tour in 62nd. In ’89 he went 23rd and 11th. In ’90, of course, he won the Giro and finished the Tour in 7th. Indurain’s rise was more gradual, less outwardly suspicious; he finished 97th in the ’87 Tour, but gradually climbed the ranks up to 47th, 17th and 10th before winning.
What makes all three of these riders of a piece is the fact that they started anonymously before rising to prominence. LeMond, Fignon, Merckx and Bernard Hinault all share in common the fact that their brilliance and potential shown early on. LeMond differs only in that he didn’t win his first Tour—he was third.
Lance Armstrong is accused of being at the center of the greatest doping program in history, the greatest sporting fraud ever perpetrated. It’s a charge we can’t really resolve. If there was a greater sporting fraud, it hasn’t been exposed. Ultimately, this isn’t a terribly important question. What the Armstrong fall has done, however, is to open the public’s eyes to the breadth of doping that has taken place. It has introduced suspicion into the cycling fan’s vocabulary. The problem before us is how to put this behind us. We may never put the genie back in the bottle, but a TRC has the ability to educate us on more than just who doped; it has the ability to clear those who did not dope.
Aside from simply dispensing the truth, a TRC will freshly frame the achievement of riders like LeMond, riders who would have accomplished more were it not for the rise of EPO. A TRC that reaches back to 1990 will give us a new way to define courage.
Image: John Pierce, Photosport International